Business Portfolio Restructuring and Financial Targets under VISION2023
First written in FY2021. 7 of 13 entries say "Restated". Latest entry: 2026-05-12.
0 other companies' latest entry also says "Cited as achieved".
- 2026-05-12Cited as achievedEarnings
「In fiscal 2025, net sales reached a record high for the fourth consecutive fiscal year, operating income for the fifth consecutive fiscal year and net income attributable to owners of the company for the sixth consecutive fiscal year.」
The disclosure cites record highs in key financial indicators as an achievement related to the management plan following VISION2023. - FY2025-H1RestatedAnnual report
「There were no material changes during the interim consolidated accounting period to the management policies, management strategies or other matters established by our group.」
The company reconfirms that there were no material changes during the interim consolidated accounting period to its management policies, management strategies or other matters, including VISION2023. - FY2024Cited as achievedAnnual report
「The sales and operating income targets set out in VISION2023 were achieved one year ahead of schedule, and sales, operating income, income before income taxes and net income attributable to owners of the company all reached new record highs in fiscal 2023.」
The company reiterates that it achieved the VISION2023 sales and operating income targets one year ahead of schedule and that its principal profit metrics and other indicators reached new record highs in fiscal 2023. - FY2024-Q3RestatedAnnual report
「There were no material changes to the management policies, management strategies or other matters established by our Group during the cumulative third-quarter period.」
The company reconfirms that there have been no material changes to its management policies, management strategies or other matters, including VISION2023. - FY2024-Q2RestatedAnnual report
「There were no material changes to the management policies, management strategies or other matters established by our Group during the cumulative second-quarter period.」
The company reconfirms that there have been no material changes to its management policies, management strategies or other matters, including VISION2023. - FY2024-Q1RestatedAnnual report
「There were no material changes during the three-month period ended June 30 to the management policies, management strategies or other matters established by our group.」
The company reconfirms that there have been no material changes to its management policies, management strategies or other matters, including VISION2023. - FY2023AchievedAnnual report
「In fiscal 2022, the second year of the medium-term management plan, sales, operating income, income before income taxes and net income attributable to owners of the company all reached record highs. The company achieved the VISION2023 targets of ¥2.7 trillion in fiscal 2023 sales and ¥260 billion in operating income one year ahead of schedule.」
The company states that it achieved the VISION2023 targets of ¥2.7 trillion in fiscal 2023 sales and ¥260 billion in operating income one year ahead of schedule, in fiscal 2022. - FY2023-Q2RestatedAnnual report
「There were no material changes to the management policies, management strategies or other matters established by our Group during the cumulative second-quarter period.」
The company states that there have been no material changes to its management policies, management strategies or other matters, including VISION2023. - FY2023-Q1RestatedAnnual report
「There were no material changes during the three-month period ended June 30 to the management policies, management strategies or other matters established by our group.」
The company states that there have been no material changes to its management policies, management strategies or other matters, including VISION2023. - FY2022AdvancedAnnual report
「In fiscal 2021, the first year of the medium-term management plan, operating income, income before income taxes and net income attributable to owners of the company all reached record highs. The company got off to a solid start toward achieving the VISION2023 targets of ¥2.7 trillion in fiscal 2023 sales and ¥260 billion in operating income.」
In the first year of VISION2023, operating income, income before income taxes and net income reached record highs, demonstrating progress toward the fiscal 2023 targets of ¥2.7 trillion in sales and ¥260 billion in operating income. - FY2022-Q3RestatedAnnual report
「There were no material changes to the management policies, management strategies or other matters established by our Group during the cumulative third-quarter period.」
The company states that there have been no material changes to its management policies, management strategies or other matters, including VISION2023. - FY2022-Q1AdvancedAnnual report
「In formulating the medium-term management plan “VISION2023,” beginning in fiscal 2021, the company changed its operating segments as follows from the current consolidated fiscal year.」
In connection with the execution of VISION2023, the company began restructuring its operating segments in fiscal 2021 and changed to an operating structure that clarifies healthcare as a growth driver and synergies among businesses. - FY2021First statedAnnual report
「Under “VISION2023,” the company will advance “accelerating growth in Healthcare and High-Function Materials and building a resilient business foundation that enables sustainable growth” by strengthening business portfolio management and cash flow management, securing funding for growth investments, and accelerating and reinforcing the cycle of concentrating management resources on priority, new, and future-growth businesses.」
The company newly formulated VISION2023, covering fiscal 2021 through fiscal 2023, with business portfolio and cash flow management and the concentration of resources on healthcare and high-performance materials at its core. Its targets for fiscal 2023 were sales of ¥2.7 trillion, operating income of ¥260 billion, net income attributable to owners of the company of ¥200 billion, ROE of 8.4%, and ROIC of 6.1%.